03:08 AM EST, 01/28/2025 (MT Newswires) -- Ian Mortimer, Director, President and Chief Executive Officer, on January 23, 2025, sold 55,000 shares in Xenon Pharmaceuticals ( XENE ) for $2,213,997. Following the Form 4 filing with the SEC, Mortimer has control over a total of 45,602 shares of the company, with 31,302 shares held directly and 14,300 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1582313/000095017025009388/xslF345X05/ownership.xml